Enact Holdings, Inc.
ACT Nasdaq Insurance Agents, Brokers & Service Financials FY2019βFY2025
What Enact Holdings, Inc. does
No business description yet.
- Legal name
- Enact Holdings, Inc.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Feb 27, 2026
- Accession Β· CIK
- 0001823529-26-000060
0001823529
Revenue and margins
Enact Holdings, Inc. had $1.2B of revenue in fiscal 2025, up 2.8% on the year before.
Net income and earnings per share
From fiscal 2019 to 2025, diluted EPS grew 1.4% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was β in fiscal 2025, β of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Enact Holdings, Inc. returned $503M to shareholders in fiscal 2025. The diluted share count fell 5.2%.
Balance sheet
Cash, debt and the ratios that show how comfortably Enact Holdings, Inc. can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $426M | $517M | $636M | $603M | $582M |
| Debt incl. finance leases | $740M | $743M | $745M | $743M | $744M |
| Debt / equity | 0.2x | 0.2x | 0.2x | 0.1x | 0.1x |
| Total assets | $5.9B | $5.7B | $6.2B | $6.5B | $6.9B |
| Total liabilities | $1.8B | $1.6B | $1.6B | $1.5B | $1.5B |
| Shareholders' equity | $4.1B | $4.1B | $4.6B | $5.0B | $5.4B |
| Net debt (β = net cash) | $315M | $226M | $110M | $140M | $162M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β |
| F-score | β / 3 | β / 4 | 5 / 7 | 4 / 7 | 4 / 7 | 4 / 7 | 5 / 7 |
| Accruals ratio | β | β5.9% | β0.4% | 2.5% | 0.6% | 0.0% | β0.7% |
| Altman Z'' | β | β | β | β | β | β | β |
7 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | $979M | $1.1B | $1.1B | $1.1B | $1.2B | $1.2B | $1.2B |
| Interest expense | $0.0M | $18.2M | $51.0M | $51.7M | $51.9M | $51.2M | $49.9M |
| Pretax income | $718M | $472M | $695M | $898M | $852M | $878M | $859M |
| Income tax | $156M | $102M | $149M | $194M | $186M | $190M | $185M |
| Net income | $678M | $370M | $547M | $704M | $666M | $688M | $674M |
| Net income to common | β | $370M | $547M | $704M | $666M | $688M | $674M |
| Diluted EPS | $4.16 | $2.27 | $3.36 | $4.31 | $4.11 | $4.37 | $4.52 |
| Diluted shares | 0.16B | 0.16B | 0.16B | 0.16B | 0.16B | 0.16B | 0.15B |
| Cash flow | |||||||
| Cash from operations | $500M | $704M | $572M | $561M | $632M | $686M | $725M |
| Stock-based compensation | $0.0M | $0.0M | $1.5M | $9.9M | $15.3M | $18.8M | $19.0M |
| Share buybacks | β | $0.0M | $0.0M | $1.5M | $87.8M | $244M | $382M |
| Dividends paid | $250M | $437M | $200M | $251M | $213M | $112M | $121M |
| Dividends and buybacks | $250M | $437M | $200M | $252M | $301M | $356M | $503M |
| Balance sheet | |||||||
| Cash and short-term investments | $585M | $453M | $426M | $517M | $636M | $603M | $582M |
| Total debt | β | $738M | $740M | $743M | $745M | $743M | $744M |
| Total assets | β | $5.7B | $5.9B | $5.7B | $6.2B | $6.5B | $6.9B |
| Total liabilities | β | $1.8B | $1.8B | $1.6B | $1.6B | $1.5B | $1.5B |
| Shareholders' equity | $3.8B | $3.9B | $4.1B | $4.1B | $4.6B | $5.0B | $5.4B |
| Margins | |||||||
| Net margin | 69.2% | 33.5% | 48.9% | 64.3% | 57.7% | 57.3% | 54.6% |
| Returns | |||||||
| Return on equity | 17.7% | 9.6% | 13.7% | 17.2% | 15.2% | 14.3% | 13.0% |
| Return on assets | β | 6.6% | 9.5% | 12.2% | 11.2% | 10.8% | 10.1% |
| Return on tangible equity | 17.7% | 9.5% | 13.3% | 17.2% | 14.4% | 13.8% | 12.6% |
| Growth | |||||||
| Revenue growth | β | 13.0% | 1.0% | β2.0% | 5.4% | 4.2% | 2.8% |
| Net income growth | β | β45.3% | 47.6% | 28.8% | β5.5% | 3.4% | β2.0% |
| EPS growth | β | β45.4% | 48.0% | 28.3% | β4.6% | 6.3% | 3.4% |
| Share count change | β | 0.0% | 0.0% | 0.3% | β0.9% | β2.7% | β5.2% |
| Financial health | |||||||
| Debt / equity | β | 0.2x | 0.2x | 0.2x | 0.2x | 0.1x | 0.1x |
| Capital allocation | |||||||
| Stock comp / revenue | 0.0% | 0.0% | 0.1% | 0.9% | 1.3% | 1.6% | 1.5% |
| Quality scores | |||||||
| Piotroski F-score | β | β | 5.0 | 4.0 | 4.0 | 4.0 | 5.0 |
| Accruals ratio | β | β5.9% | β0.4% | 2.5% | 0.6% | 0.0% | β0.7% |
Source: SEC EDGAR XBRL filings (CIK 0001823529). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.